Mejzini, R.; Caruthers, M.H.; Schafer, B.; Kostov, O.; Sudheendran, K.; Ciba, M.; Danielsen, M.; Wilton, S.; Akkari, P.A.; Flynn, L.L.
Allele-Selective Thiomorpholino Antisense Oligonucleotides as a Therapeutic Approach for Fused-in-Sarcoma Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2024, 25, 8495.
https://doi.org/10.3390/ijms25158495
AMA Style
Mejzini R, Caruthers MH, Schafer B, Kostov O, Sudheendran K, Ciba M, Danielsen M, Wilton S, Akkari PA, Flynn LL.
Allele-Selective Thiomorpholino Antisense Oligonucleotides as a Therapeutic Approach for Fused-in-Sarcoma Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences. 2024; 25(15):8495.
https://doi.org/10.3390/ijms25158495
Chicago/Turabian Style
Mejzini, Rita, Marvin H. Caruthers, Balazs Schafer, Ondrej Kostov, Kavitha Sudheendran, Marija Ciba, Mathias Danielsen, Steve Wilton, Patrick Anthony Akkari, and Loren L. Flynn.
2024. "Allele-Selective Thiomorpholino Antisense Oligonucleotides as a Therapeutic Approach for Fused-in-Sarcoma Amyotrophic Lateral Sclerosis" International Journal of Molecular Sciences 25, no. 15: 8495.
https://doi.org/10.3390/ijms25158495
APA Style
Mejzini, R., Caruthers, M. H., Schafer, B., Kostov, O., Sudheendran, K., Ciba, M., Danielsen, M., Wilton, S., Akkari, P. A., & Flynn, L. L.
(2024). Allele-Selective Thiomorpholino Antisense Oligonucleotides as a Therapeutic Approach for Fused-in-Sarcoma Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences, 25(15), 8495.
https://doi.org/10.3390/ijms25158495
